Case Reports / Case Series
Tuesday, October 26, 2021: 5:00 PM-7:00 PM
Exhibit Hall (Rosen Shingle Creek)
Non-Intensive Exercise to Prepare for Intensive, Task-Oriented Rehabilitation in People with Progressive Multiple Sclerosis: A Two-Participant Case Study
Cameron S Mang, PhD, University of Regina;
Kristen E Plandowski, BSc, University of Regina;
Eduardo A Toledo-Aldana, BSc, University of Regina;
Sarah J Donkers, PT, PhD, University of Saskatchewan
Positive Outcome with Alemtuzumab in Hispanic Puerto Rican Woman with Highly Active Multiple Sclerosis after Various Failed Disease Modifying Therapies
Evián Pérez Rivera, BS, San Juan Bautista School of Medicine;
Mayra I González Torres, BS, San Juan Bautista School of Medicine;
Ashley N García Aponte, BS, San Juan Bautista School of Medicine;
Viviana Martinez Maldonado, BS, San Juan Multiple Sclerosis Center;
Ramón Vega Corteguera, BS, San Juan Multiple Sclerosis Center;
Ivonne Vicente Loperena, MD, San Juan Multiple Sclerosis Center;
Angel Chinea, MD, San Juan MS Center
Immunotherapy-Responsive Post COVID-19 Central Nervous System Inflammatory Syndrome, a Case Report
Gina S Perez, MD, University of Oklahoma Health Sciences Center;
Courtney Iser, MD, University of Oklahoma Health Sciences Center;
Sara Habib, MD, University of Oklahoma Health Sciences Center;
Juliane Chainakul, APRN-CNS, University of Oklahoma Health Sciences Center;
Sarah Durica, MD, University of Oklahoma Health Sciences Center;
Danny Samkutty, MD, University of Oklahoma Health Sciences Center;
Evgeny Sidorov, MD, University of Oklahoma Health Sciences Center;
Ahmad Al Awwad, MD, University of Oklahoma Health Sciences Center;
Masoom Desai, MD, University of Oklahoma Health Sciences Center;
Jorge Ortiz, MD, University of Oklahoma Health Sciences Center;
Nidhiben Anadani, MD, University of Oklahoma Health Sciences Center;
David Gordon, MD, University of Oklahoma Health Sciences Center
Case Report of a Severe Cutaneous Lupus Erythematosus Flare in a Patient Treated with Eculizumab for the Treatment of Neuromyeltis Optica Spectrum Disorder
Jennifer Chester, FNP-BC, MSCN, Kansas City MS Center at College Park Specialty;
Leah Hurd, RN, BSN, College Park Neurology;
Tyler Kaplan, MD, Rush University Medical Center, University of Utah;
Mark Box, MD, Carondolet;
Jeffrey Kaplan, MD, College Park Neurology
Treatment Resistant Tinea Corporis in Multiple Sclerosis Patients Treated with Ocrelizumab
Michelle Maynard, PharmD, BCPS, Froedtert and the Medical College of Wisconsin;
Carmen Raschka, RN, Froedtert Hospital;
Mokshal H Porwal, BSc, Medical College of Wisconsin;
Ahmed Z Obeidat, MD, PhD, Medical College of Wisconsin
Multiple Sclerosis-like Features in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Red Flag, Red Herring, or Regular Occurrence?
Samuel B Marcucci, BS, University of Cincinnati;
Rosemarie Walch, DO, University of Cincinnati;
Ameneh Zare-Shahabadi, MD/MPH, West Virginia University;
Lawrence P Goldstick, MD, University of Cincinnati;
Allison Jordan, DO, University of Cincinnati;
Roman Kassa, MD/PhD, University of Cincinnati;
Abdelkader Mahammedi, MD, University of Cincinnati;
Aram Zabeti, MD, University of Cincinnati
Multiple Sclerosis in a Patient with Neurofibromatosis Type-1
Siddharth Ninan, MBBS, UNC Hospitals;
Gershon Timothy, MD, PhD, UNC Hospitals;
Robert Greenwood, MD, UNC Hospitals;
Clara Zelasky, PA-C, UNC Hospitals;
Stephanie Iyer, PharmD, CPP, UNC Hospitals;
Irena Dujmovic-Basuroski, MD, UNC Hospitals